Short-term 30-day adverse events following awake versus asleep deep brain stimulation for movement disorders: a nationwide registry-based study
Introduction: Deep Brain Stimulation (DBS) is FDA-approved for the management of medically refractory movement disorders and epilepsy. We aim to assess potential differences in adverse eventsamong patients undergoing asleep versus awake DBS, to facilitate a patient centric decision-making process fo...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Brain and Spine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772529425002127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|